Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intraoperative Dexmedetomidine for Prevention of Postoperative Delirium in Patients Undergoing Hip Fracture Surgery: a Pre-post Study

NCT07867899 is registered in ClinicalTrials.gov with Peter Gaarsdal Uhrbrand as lead sponsor.

NCT NCT07867899
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07867899 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intraoperative Dexmedetomidine for Prevention of Postoperative Delirium in Patients Undergoing Hip Fracture Surgery: a Pre-post Study
Lead sponsor
Peter Gaarsdal Uhrbrand
Phase
Observational
Overall status
Recruiting
Start date
October 1, 2026
Completion date
April 14, 2027
Enrollment
242 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

delirium - postoperative, delirium prevention, dexmedetomidine, dexmedetomidine infusion